Report Description

GBI Research’s new report, “The Future of the In-Vitro Diagnostics Market to 2016 – Increasing Diagnostic Procedures Drive Demand” provides key data, information and analysis on the global in-vitro diagnostics market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on seven in-vitro diagnostics market categories – Clinical Chemistry, Genetic Testing, Histology and Cytology, Immuno Chemistry, Infectious Immunology, Microbiology Culture and Haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Belgium, Netherlands, Japan, China, India, Australia, Taiwan, republic of Korea, Brazil, Argentina, Mexico, Israel and South Africa.
Global Market size and company share data for seven In-Vitro Diagnostics market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture and haematology.
Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
Competitive landscape and key company profiles. Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, Becton, Dickinson (BD), Bio-Rad Laboratories, Inverness Medical Innovations, Sysmex, Gen-Probe and Dade Behring.
Key in-pipeline products and technologies expected to hit the global In-Vitro Diagnostics market in the near future.

Reasons to buy

Develop business strategies by understanding the trends and developments that are driving the In-Vitro Diagnostics market globally.
Design and develop your product development, marketing and sales strategies.
Exploit M&A opportunities by identifying market players with the most innovative pipeline. Develop market-entry and market expansion strategies.
Identify key players best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
What’s the next big thing in the In-Vitro Diagnostics market landscape? – Identify, understand and capitalize
Make more informed business decisions from the insightful and in-depth analysis of the In-Vitro Diagnostics market and the factors shaping it.

1 Table of Contents 3

1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction and Overview 11

2.1 In-Vitro-Diagnostics (IVD) Overview 11

3 Global In-Vitro Diagnostics (IVD) Market: Market Characterization 12

3.1 Global In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 12
3.2 Global In-Vitro Diagnostics (IVD) Market, Revenue Forecasts ($m), 2009 – 2016 13
3.3 Global In-Vitro Diagnostics (IVD) Market, Company Share (%), 2008 14
3.4 Global In-Vitro Diagnostics (IVD) Market, Key Market Trends 15
3.4.1 Entry of Diagnostic Imaging Players into the In-Vitro Diagnostics (IVD) Market Has Set Stage for New Technologies to Be Developed By Marrying the Two Disciplines    15
3.4.2 Large Number of Private Equity/ Venture Capital (PE/VC) Investments and Collaborations in the In-Vitro Diagnostics (IVD) Sector to Fuel Innovation 16
3.4.3 Consolidation of Laboratories across the World 16
3.5 Global In-Vitro Diagnostics (IVD) Market: Key Technology Trends 17
3.5.1 Emerging Technologies for Cutting Lab Costs 17
3.5.2 New Technologies Improve Speed and Accuracy 18
3.6 Global In-Vitro Diagnostics (IVD) Market, Market Drivers 20
3.6.1 Economic Market Drivers 20
3.6.2 Technological Market Drivers 22
3.6.3 Regulatory Market Drivers 22
3.6.4 Social Market Drivers 22
3.7 In-Vitro Diagnostics (IVD) Market, Market Restraints 23
3.7.1 Economic Market Restraints 23
3.7.2 Social Market Restraints 24

4 Global In-Vitro Diagnostics (IVD) Market: Category Analysis and Forecasts 25

4.1 Clinical Chemistry Market: Market Characterization 25
4.1.1 Global Clinical Chemistry Market, Revenue ($m), 2002–2009 25
4.1.2 Global Clinical Chemistry Market, Revenue Forecasts ($m), 2009–2016 26
4.1.3 Global Clinical Chemistry Market, Company Share (%), 2008 27
4.1.4 Clinical Chemistry Market: Market Drivers 28
4.1.5 Clinical Chemistry Market: Market Restraints 28
4.2 Immuno Chemistry Market: Market Characterization 29
4.2.1 Global Immuno Chemistry Market, Revenue ($m), 2002 – 2009 29
4.2.2 Global Immuno Chemistry Market, Revenue Forecast ($m), 2009 – 2016 31
4.2.3 Global Immuno Chemistry Market, Company Share (%), 2008 32
4.2.4 Immuno Chemistry Market: Market Drivers 33
4.2.5 Immuno Chemistry Market: Market Restraints 34
4.3 Haematology Market: Market Characterization 35
4.3.1 Global Haematology Market, Revenues ($m), 2002 – 2009 35
4.3.2 Global Haematology Market, Revenue Forecasts ($m), 2009 – 2016 36
4.3.3 Global Haematology Market, Company Share (%), 2008 37
4.3.4 Haematology Market: Market Drivers 37
4.3.5 Haematology Market: Market Restraints 38
4.4 Histology and Cytology Market: Market Characterization 39
4.4.1 Global Histology and Cytology Market, Revenue ($m), 2002 – 2009 39
4.4.2 Global Histology and Cytology Market, Revenue Forecasts ($m),  2009 – 2016 40
4.4.3 Global Histology and Cytology Market, Company Share (%), 2008 41
4.4.4 Histology and Cytology Market: Market Drivers 42
4.4.5 Histology and Cytology Market: Market Restraints 42
4.5 Microbiology Culture Market: Market Characterization 43
4.5.1 Global Microbiology Culture Market, Revenue ($m), 2002 – 2009 43
4.5.2 Global Microbiology Culture Market, Revenue Forecasts ($m), 2009 – 2016 44
4.5.3 Global Microbiology Culture Market, Company Share (%), 2008 45
4.5.4 Global Microbiology Culture Market: Market Drivers 45
4.5.5 Microbiology Culture Market: Market Restraints 46
4.6 Infectious Immunology Market: Market Characterization 47
4.6.1 Global Infectious Immunology Market, Revenue ($m), 2002 – 2009 47
4.6.2 Global Infectious Immunology Market, Revenue Forecasts ($m),  2009 – 2016 48
4.6.3 Global Infectious Immunology Market, Company Share (%), 2008 49
4.6.4 Global Infectious Immunology Market: Market Drivers 49
4.6.5 Global Infectious Immunology Market: Market Restraints 50
4.7 Genetic Testing Market: Market Characterization 51
4.7.1 Global Genetic Testing Market, Revenue ($m), 2002 – 2009 51
4.7.2 Global Genetic Testing Market, Revenue Forecasts ($m), 2009 – 2016 52
4.7.3 Global Genetic Testing Market, Company Share (%), 2008 53
4.7.4 Global Genetic Testing Market: Market Drivers 53
4.7.5 Global Genetic Testing Market: Market Restraints 54

5 Global In-Vitro Diagnostics (IVD) Market: Country Analysis and Forecasts 55

5.1 Global In-Vitro Diagnostics (IVD)Market: Geographic Trends Analysis 55
5.2 Market Characterization, North America, 2002 – 2016 56
5.2.1 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 56
5.2.2 The US In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 57
5.2.3 Canada In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 58
5.2.4 North America In-Vitro Diagnostics (IVD) Market, Market Drivers 60
5.2.5 North America In-Vitro Diagnostics (IVD) Market, Market Restraints 60
5.3 Market Characterization, Europe, 2002 – 2016 61
5.3.1 The UK In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 61
5.3.2 The UK In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 – 2016 62
5.3.3 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 63
5.3.4 Germany In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 64
5.3.5 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 65
5.3.6 France In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 67
5.3.7 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 68
5.3.8 Italy In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 69
5.3.9 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 70
5.3.10 Spain In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 71
5.3.11 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 72
5.3.12 Belgium In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 73
5.3.13 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m),  2002 – 2009    74
5.3.14 The Netherlands In-Vitro Diagnostics (IVD) Market, Revenue ($m),  2009 – 2016    75
5.3.15 Europe In-Vitro Diagnostics (IVD) Market, Market Drivers 76
5.3.16 Europe In-Vitro Diagnostics (IVD) Market, Market Restraints 76
5.4 Market Characterization, Asia Pacific, 2002 – 2016 77
5.4.1 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 77
5.4.2 Japan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 78
5.4.3 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 79
5.4.4 China In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 81
5.4.5 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 82
5.4.6 India In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 83
5.4.7 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 84
5.4.8 Australia In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 85
5.4.9 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 86
5.4.10 Taiwan In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 87
5.4.11 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009    88
5.4.12 Republic of Korea In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016    89
5.4.13 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Drivers 90
5.4.14 Asia Pacific In-Vitro Diagnostics (IVD) Market, Market Restraints 91
5.5 Market Characterization, South and Central America, 2002 – 2016 91
5.5.1 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 91
5.5.2 Brazil In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 93
5.5.3 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 94
5.5.4 Argentina In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 95
5.5.5 Mexico In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 96
5.5.6 Mexico In-Vitro Diagnostics (IVD) Market, Revenues ($m), 2009 – 2016 97
5.5.7 South and Central America In-Vitro Diagnostics (IVD) Market, Market Drivers 98
5.5.8 South and Central America In-Vitro Diagnostics (IVD) Market, Market Restraints 98
5.6 Market Characterization, Middle East and Africa, 2002 – 2016 99
5.6.1 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 99
5.6.2 Israel In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 100
5.6.3 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2002 – 2009 101
5.6.4 South Africa In-Vitro Diagnostics (IVD) Market, Revenue ($m), 2009 – 2016 102
5.6.5 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Drivers 103
5.6.6 Middle East and Africa In-Vitro Diagnostics (IVD) Market, Market Restraints 103

6 Global In-Vitro Diagnostics (IVD) Market: Strategic Competitive Assessment 104

6.1 Key Market Participants 104
6.1.1 F. Hoffmann-La Roche Ltd 104
6.1.2 Siemens Medical Solutions 106
6.1.3 Abbott Laboratories 108
6.1.4 Beckman Coulter, Inc. 110
6.1.5 bioMerieux Sa 113
6.1.6 Ortho-Clinical Diagnostics 114
6.1.7 Becton, Dickinson and Company 115
6.1.8 Bio-Rad Laboratories, Inc. 116
6.1.9 Inverness Medical Innovations, Inc 117

7 Global In-Vitro Diagnostics (IVD) Market: Product Pipeline Analysis 120

7.1 Pipeline Products Analysis by Category 120
7.1.1 Pipeline Products Analysis: Immuno Chemistry Market 121
7.1.2 Pipeline Products Analysis: Infectious Immunology 122
7.2 Key Pipeline Products Currently Undergoing Development 122
7.2.1 Clinical Chemistry Pipeline Products 122
7.2.2 Genetic Testing 122
7.2.3 Haematology 123
7.2.4 Immunochemistry 124
7.2.5 Infectious Immunology 125
7.2.6 Microbiology Culture 126
7.2.7 Histology and Cytology 126

8 Global In-Vitro Diagnostics (IVD) Market: Consolidation Landscape 127

8.1 Deals by Type, 2006 – 2009 127
8.2 Deals by Value and Volume, 2006 – 2009 128
8.3 List of Deals in 2009 128
8.4 Top 10 Acquisitions By Value, 2009 131
8.4.1 Agilent Technologies Receives Shareholders Approval To Acquire Varian 131
8.4.2 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 131
8.4.3 MDS Receives Shareholder Approval To Sell MDS Analytical Technologies To Danaher 132
8.4.4 Thermo Fisher Scientific Completes Acquisition Of B.R.A.H.M.S. 132
8.4.5 Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital    132
8.4.6 Becton, Dickinson and Company Completes Acquisition Of HandyLab 133
8.4.7 Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn    133
8.4.8 Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 133
8.4.9 Gen-Probe Acquires Tepnel Life Sciences 134

9 Appendix 135

9.1 Definitions 135
9.1.1 Clinical Chemistry 135
9.1.2 Immunochemistry Test Reagents 136
9.1.3 Haematology 137
9.1.4 Histology And Cytology 138
9.1.5 Microbiology Culture 139
9.1.6 Infectious Immunology 139
9.1.7 Genetic Testing 140
9.2 Acronyms 140
9.3 Methodology 140
9.3.1 Secondary Research 141
9.3.2 Primary Research 141
9.3.3 Models 142
9.3.4 Forecasts 142
9.3.5 Expert Panels 142
9.4 Contact Us 142
9.5 Disclaimer 142

1.1 List of Tables

Table 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009 12
Table 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016 13
Table 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share ($m), 2008 14
Table 4: Clinical Chemistry Market, Global, Revenue ($m), 2002–2009 25
Table 5: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016 26
Table 6: Clinical Chemistry Market, Global, Company Share ($m), 2008 27
Table 7: Immuno Chemistry Market, Global, Revenue ($m), 2002–2009 30
Table 8: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016 31
Table 9: Immuno Chemistry Market, Global, Company Share ($m), 2008 32
Table 10: Haematology Market, Global, Revenues ($m), 2002–2009 35
Table 11: Haematology Market, Global, Revenue ($m), 2009–2016 36
Table 12: Haematology Market, Global, Company Share ($m), 2008 37
Table 13: Histology and Cytology Market, Global, Revenue ($m), 2002–2009 39
Table 14: Histology and Cytology Market, Global, Revenue ($m), 2009–2016 40
Table 15: Histology and Cytology Market, Global, Company Share ($m), 2008 41
Table 16: Microbiology Culture Market, Global, Revenue ($m), 2002–2009 43
Table 17: Microbiology Culture Market, Global, Revenue ($m), 2009–2016 44
Table 18: Microbiology Culture Market, Global, Company Share ($m), 2008 45
Table 19: Infectious Immunology Market, Global, Revenue ($m), 2002–2009 47
Table 20: Infectious Immunology Market, Global, Revenue ($m), 2009–2016 48
Table 21: Infectious Immunology Market, Global, Company Share ($m), 2008 49
Table 22: Genetic Testing Market, Global, Revenue ($m), 2002–2009 51
Table 23: Genetic Testing Market, Global, Revenue ($m), 2009–2016 52
Table 24: Global Genetic Testing Market, Global, Company Share ($m), 2008 53
Table 25: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009 56
Table 26: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016 57
Table 27: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009 58
Table 28: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016 59
Table 29: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009 61
Table 30: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016 62
Table 31: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009 63
Table 32: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016 64
Table 33: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009 66
Table 34: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016 67
Table 35: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009 68
Table 36: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016 69
Table 37: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009 70
Table 38: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016 71
Table 39: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009 72
Table 40: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016 73
Table 41: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009 74
Table 42: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016 75
Table 43: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009 77
Table 44: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016 78
Table 45: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009 80
Table 46: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016 81
Table 47: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 82
Table 48: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 83
Table 49: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009 85
Table 50: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016 86
Table 51: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009 87
Table 52: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016 88
Table 53: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009 89
Table 54: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016 90
Table 55: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009 92
Table 56: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016 93
Table 57: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009 94
Table 58: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016 95
Table 59: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009 96
Table 60: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016 97
Table 61: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009 99
Table 62: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016 100
Table 63: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009 101
Table 64: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016 102
Table 65: Roche’s Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 104
Table 66: Roche In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 105
Table 67: Siemens Medical Solutions In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 107
Table 68: Siemen’s Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 108
Table 69: Abbott Laboratories’ Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 109
Table 70: Abbott Laboratories In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 110
Table 71: Beckman Coulter’s Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market,
2007–2009 112
Table 72: Beckman Coulter, Inc. In-Vitro Diagnostics (IVD) Pipeline Products 113
Table 73: bioMerieux’s Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009    114
Table 74: bioMerieux Sa, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 114
Table 75: Ortho-Clinical Diagnostics, In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 115
Table 76: Becton Dickinson, Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market,
2007–2009 116
Table 77: Becton, Dickinson Inc. In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 116
Table 78: Bio-Rad, Merger and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 117
Table 79: Inverness Medical Innovations, Inc., Mergers and Acquisitions, In-Vitro Diagnostics (IVD) Market, 2007–2009 118
Table 80: Inverness Medical Innovations In-Vitro Diagnostics (IVD) Pipeline Product Portfolio 119
Table 81: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2009 120
Table 82: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 121
Table 83: Infectious Immunology Market, Global, 2009 122
Table 84: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009 127
Table 85: Key Deals, Global In-Vitro Diagnostics (IVD) Market, 2009 128

1.2 List of Figures

Figure 1: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2002-2009 12
Figure 2: In-Vitro Diagnostics (IVD) Market, Global, Revenue ($m), 2009-2016 13
Figure 3: In-Vitro Diagnostics (IVD) Market, Global, Company Share (%), 2008 14
Figure 4: Global In-Vitro Diagnostics (IVD) Market: Key Market Trends 15
Figure 5: Global Laboratory Consolidation Landscape, 2005–2009 16
Figure 6: Global In Vitro Diagnostics Market: Key Technology Trends 17
Figure 7: Global In-Vitro Diagnostics (IVD) Market: Drivers and Restraints 19
Figure 8: List of Retail Clinics in the US and Diagnostic In-Vitro Diagnostics (IVD) Tests Offered    21
Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2002–2009 25
Figure 10: Clinical Chemistry Market, Global, Revenue ($m), 2009–2016 26
Figure 11: Clinical Chemistry Market, Global, Company Share (%), 2008 27
Figure 12: Immuno Chemistry Market, Global, Revenue ($m), 2002–2009 29
Figure 13: Immuno Chemistry Market, Global, Revenue ($m), 2009–2016 31
Figure 14:  Immuno Chemistry Market, Global, Company Share (%),2008 32
Figure 15: Haematology Market, Global, Revenue ($m), 2002–2009 35
Figure 16: Haematology Market, Global, Revenue ($m), 2009–2016 36
Figure 17: Haematology Market, Global, Company Share (%), 2008 37
Figure 18: Histology and Cytology Market, Global, Revenue ($m), 2002–2009 39
Figure 19: Histology and Cytology Market, Global, Revenue ($m), 2009–2016 40
Figure 20: Histology and Cytology Market, Global, Company Share (%), 2008 41
Figure 21: Microbiology Culture Market, Global, Revenue ($m), 2002–2009 43
Figure 22: Microbiology Culture Market, Global, Revenue ($m), 2009–2016 44
Figure 23: Microbiology Market, Global, Company Share (%),2008 45
Figure 24: Infectious Immunology Market, Global, Revenue ($m), 2002–2009 47
Figure 25: Infectious Immunology Market, Global, Revenue ($m), 2009–2016 48
Figure 26: Infectious Immunology Market, Global, Company Share (%), 2008 49
Figure 27: Genetic Testing Market, Global, Revenue ($m), 2002–2009 51
Figure 28: Genetic Testing Market, Global, Revenue ($m), 2009–2016 52
Figure 29: Global Genetic Testing Market, Global, Company Share (%),2008 53
Figure 30: In-Vitro Diagnostics (IVD) Market, Global, Geographic Trends Analysis 55
Figure 31: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2002-2009 56
Figure 32: In-Vitro Diagnostics (IVD) Market, US, Revenue ($m), 2009-2016 57
Figure 33: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2002-2009 58
Figure 34: In-Vitro Diagnostics (IVD) Market, Canada, Revenue ($m), 2009-2016 59
Figure 35: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2002-2009 61
Figure 36: In-Vitro Diagnostics (IVD) Market, UK, Revenue ($m), 2009-2016 62
Figure 37: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2002-2009 63
Figure 38: In-Vitro Diagnostics (IVD) Market, Germany, Revenue ($m), 2009-2016 64
Figure 39: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2002-2009 65
Figure 40: In-Vitro Diagnostics (IVD) Market, France, Revenue ($m), 2009-2016 67
Figure 41: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2002-2009 68
Figure 42: In-Vitro Diagnostics (IVD) Market, Italy, Revenue ($m), 2009-2016 69
Figure 43: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2002-2009 70
Figure 44: In-Vitro Diagnostics (IVD) Market, Spain, Revenue ($m), 2009-2016 71
Figure 45: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2002-2009 72
Figure 46: In-Vitro Diagnostics (IVD) Market, Belgium, Revenue ($m), 2009-2016 73
Figure 47: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2002-2009 74
Figure 48: In-Vitro Diagnostics (IVD) Market, The Netherlands, Revenue ($m), 2009-2016 75
Figure 49: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2002-2009 77
Figure 50: In-Vitro Diagnostics (IVD) Market, Japan, Revenue ($m), 2009-2016 78
Figure 51: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2002-2009 79
Figure 52: In-Vitro Diagnostics (IVD) Market, China, Revenue ($m), 2009-2016 81
Figure 53: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 82
Figure 54: In-Vitro Diagnostics (IVD) Market, India, Revenue ($m), 2002-2009 83
Figure 55: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2002-2009 84
Figure 56: In-Vitro Diagnostics (IVD) Market, Australia, Revenue ($m), 2009-2016 85
Figure 57: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2002-2009 86
Figure 58: In-Vitro Diagnostics (IVD) Market, Taiwan, Revenue ($m), 2009-2016 87
Figure 59: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2002-2009 88
Figure 60: In-Vitro Diagnostics (IVD) Market, Republic of Korea, Revenue ($m), 2009-2016 89
Figure 61: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2002-2009 91
Figure 62: In-Vitro Diagnostics (IVD) Market, Brazil, Revenue ($m), 2009-2016 93
Figure 63: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2002-2009 94
Figure 64: In-Vitro Diagnostics (IVD) Market, Argentina, Revenue ($m), 2009-2016 95
Figure 65: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2002-2009 96
Figure 66: In-Vitro Diagnostics (IVD) Market, Mexico, Revenue ($m), 2009-2016 97
Figure 67: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2002-2009 99
Figure 68: In-Vitro Diagnostics (IVD) Market, Israel, Revenue ($m), 2009-2016 100
Figure 69: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2002-2009 101
Figure 70: In-Vitro Diagnostics (IVD) Market, South Africa, Revenue ($m), 2009-2016 102
Figure 71: In-Vitro Diagnostics (IVD) Market, Global, Pipeline Products Analysis by Category, 2009 120
Figure 72: Immuno Chemistry Market, Global, Pipeline Products Analysis, 2009 121
Figure 73: Infectious Immunology Market, Global, 2009 122
Figure 74: Deals By Type, Global In-Vitro Diagnostics (IVD) Market, 2006-2009 127
Figure 75: Deals By Value and Volume, Global In-Vitro Diagnostics (IVD) Market, Value ($m), 2006-2009 128
Figure 76: GBI Research Methodology 141